The global biotechnology reagents & kits market is on the cusp of a remarkable expansion, with a projected value of USD 1.37 trillion by 2030. This translates to a staggering CAGR (compound annual growth rate) of 11.0% during the forecast period of 2023-2030, according to a recent market analysis. The market was estimated at USD 596.3 billion in 2022. This press release explores...

The global biomarkers market size reached US$ 68.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 139.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028. Biomarkers, alternatively referred to as biological markers, are molecules or genes that are utilized as indicators of the health and status of an organ, cell, or tissue. They are...

The global biomarkers market size reached US$ 68.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 139.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028. Biomarkers, alternatively referred to as biological markers, are molecules or genes that are utilized as indicators of the health and status of an organ, cell, or tissue. They are...

The Biomarkers Market is set to experience exponential growth, with projections indicating it will reach a valuation of $201.33 billion by 2031, growing at a robust CAGR of 14.3% from 2024 to 2031, according to Meticulous Research®. This upward trajectory is driven by a confluence of factors including increasing pharmaceutical research investments, advancements in...

The latest research study “Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that the global biomarkers market size reached US$ 68.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 139.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028. Biomarkers,...

The global biomarkers market is poised for substantial growth, with a projected value of USD 182.6 billion by the year 2030. According to recent market analysis, the market size for biomarkers was estimated at USD 66.8 billion in 2022, indicating a robust upward trajectory with a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period from 2023 to 2030. Biomarkers, measurable...

Cancer Biomarkers Market Outlook Cancer Biomarkers are biological molecules found in blood, other body fluids, or tissues that indicate the presence of cancer. These markers can be DNA, RNA, proteins, or other substances produced by cancer cells or by the body in response to cancer. Cancer Biomarkers is growing rapidly as an industry due to growing preference for wireless connectivity among...

The global cell-based assay market is anticipated to grow at a considerable CAGR of 7.7% during the forecast period. The increasing technological-based advancement by key players operating in the market and various approvals for assays-based products are key factors that are propelling the market growth. The companies are investing in the development of new and technology-based products...

The Cholesterol Test Market was valued at USD 6.35 billion in 2022 and is expected to reach USD 11.58 billion in 2030 and grow at a CAGR of 7.8% over the forecast period of 2023-2030. The Driving Forces of Market Harmony: Several key factors orchestrate the market's crescendo: Rising prevalence of cardiovascular diseases: With heart disease a leading cause of mortality...

The clinical laboratory market is highly competitive and fragmented, with many players operating in the market. These players offer a variety of diagnostic tests and services, including clinical chemistry, hematology, microbiology, immunology, and genetic testing.  The clinical laboratory market is a rapidly growing industry that provides critical diagnostic testing services to...